BioClinica® announced that it has acquired global patient recruitment and retention firm, MediciGroup. The acquisition includes affiliates MediciGlobal, Ltd. and Access to Patients, LLC. Medici also provides a lost-to-follow-up patient locate service (L2FU®) that finds missing patients globally. The acquisition adds proprietary technologies and processes to BioClinica’s services as well as the ability to integrate recruitment metrics with BioClinica’s system, to help manage clinical trials in real time.
Liz Moench, founder and CEO of Medici, will lead the company’s global patient recruitment and retention services, headquartered at BioClinica’s Philadelphia-area office.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.